UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051702
Receipt number R000059004
Scientific Title Exploratory research using existing samples on the effect of yogurt intake on immune function for healthy adults (2nd)
Date of disclosure of the study information 2023/07/25
Last modified on 2024/04/23 12:35:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research using existing samples on the effect of yogurt intake on immune function for healthy adults (2nd)

Acronym

Exploratory research using existing samples on the effect of yogurt intake on immune function for healthy adults (2nd)

Scientific Title

Exploratory research using existing samples on the effect of yogurt intake on immune function for healthy adults (2nd)

Scientific Title:Acronym

Exploratory research using existing samples on the effect of yogurt intake on immune function for healthy adults (2nd)

Region

Japan


Condition

Condition

N/A (Healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of yogurt intake on immune function

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Titers and antigen binding-avidity of anti-SARS-CoV-2 antibodies in plasma

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects examined in the other study (UMIN000045839)

Key exclusion criteria

Subjects whose specimen have not been obtained or remained enough volume for analysis in the other study (UMIN000045839)

Target sample size

108


Research contact person

Name of lead principal investigator

1st name Toshihiro
Middle name
Last name Sashihara

Organization

Meiji Co., Ltd.

Division name

R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachiouji, Tokyo, Japan

TEL

81-42-632-5842

Email

toshihiro.sashihara@meiji.com


Public contact

Name of contact person

1st name Toshihiro
Middle name
Last name Sashihara

Organization

Meiji Co., Ltd.

Division name

R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachiouji, Tokyo, Japan

TEL

81-42-632-5842

Homepage URL


Email

toshihiro.sashihara@meiji.com


Sponsor or person

Institute

Meiji Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tokushima University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Meiji Institutional Review Board

Address

1-29-1 Nanakuni, Hachiouji, Tokyo, Japan

Tel

81-42-632-5900

Email

MEIJI.IRB@meiji.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 04 Month 07 Day

Date of IRB

2023 Year 04 Month 17 Day

Anticipated trial start date

2023 Year 07 Month 26 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is conducted using samples obtained in the other study (UMIN000045839). There is no intervention and invasion in this study.


Management information

Registered date

2023 Year 07 Month 24 Day

Last modified on

2024 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059004


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name